- Home
- NYMT vs CRMD Comparison
NYMT vs CRMD Comparison
Compare NYMT & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYMT
- CRMD
- Stock Information
- Founded
- NYMT 2003
- CRMD 2006
- Country
- NYMT United States
- CRMD United States
- Employees
- NYMT N/A
- CRMD N/A
- Industry
- NYMT Real Estate Investment Trusts
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- NYMT Real Estate
- CRMD Health Care
- Exchange
- NYMT Nasdaq
- CRMD Nasdaq
- Market Cap
- NYMT 538.5M
- CRMD 645.0M
- IPO Year
- NYMT 2004
- CRMD 2010
- Fundamental
- Price
- NYMT $5.43
- CRMD $7.67
- Analyst Decision
- NYMT Buy
- CRMD Strong Buy
- Analyst Count
- NYMT 5
- CRMD 6
- Target Price
- NYMT $7.13
- CRMD $14.50
- AVG Volume (30 Days)
- NYMT 879.3K
- CRMD 2.6M
- Earning Date
- NYMT 04-30-2025
- CRMD 05-08-2025
- Dividend Yield
- NYMT 14.72%
- CRMD N/A
- EPS Growth
- NYMT N/A
- CRMD N/A
- EPS
- NYMT N/A
- CRMD N/A
- Revenue
- NYMT $143,242,000.00
- CRMD $43,472,170.00
- Revenue This Year
- NYMT N/A
- CRMD $207.65
- Revenue Next Year
- NYMT $20.60
- CRMD $50.13
- P/E Ratio
- NYMT N/A
- CRMD N/A
- Revenue Growth
- NYMT N/A
- CRMD N/A
- 52 Week Low
- NYMT $5.01
- CRMD $3.61
- 52 Week High
- NYMT $7.25
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- NYMT 32.50
- CRMD 47.85
- Support Level
- NYMT $5.30
- CRMD $6.32
- Resistance Level
- NYMT $5.61
- CRMD $7.71
- Average True Range (ATR)
- NYMT 0.33
- CRMD 0.47
- MACD
- NYMT -0.07
- CRMD 0.23
- Stochastic Oscillator
- NYMT 26.92
- CRMD 92.41
About NYMT New York Mortgage Trust Inc.
New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.